SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-23-009080
Filing Date
2023-04-03
Accepted
2023-04-03 16:18:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A zvra20230403_defa14a.htm DEFA14A 17847
2 picture1.jpg GRAPHIC 49202
3 picture2.jpg GRAPHIC 45685
  Complete submission text file 0001437749-23-009080.txt   149907
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36913 | Film No.: 23792869
SIC: 2834 Pharmaceutical Preparations